Compagnie Lombard Odier SCmA’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.9M | Sell |
190,007
-26,791
| -12% | -$1.87M | 0.15% | 79 |
|
|
2025
Q4 | $14.4M | Buy |
216,798
+34,406
| +19% | +$2.22M | 0.16% | 75 |
|
|
2025
Q3 | $12.3M | Sell |
182,392
-720
| -0.4% | -$57K | 0.14% | 81 |
|
|
2025
Q2 | $16M | Buy |
183,112
+53,092
| +41% | +$4.16M | 0.21% | 67 |
|
|
2025
Q1 | $8.88M | Sell |
130,020
-4,790
| -4% | -$391K | 0.11% | 91 |
|
|
2024
Q4 | $10.5M | Sell |
134,810
-16,473
| -11% | -$1.22M | 0.15% | 74 |
|
|
2024
Q3 | $10.1M | Sell |
151,283
-4,431
| -3% | -$364K | 0.16% | 77 |
|
|
2024
Q2 | $17.7M | Buy |
155,714
+3,099
| +2% | +$392K | 0.3% | 60 |
|
|
2024
Q1 | $21.2M | Buy |
152,615
+25,700
| +20% | +$3.23M | 0.37% | 55 |
|
|
2023
Q4 | $15.7M | Buy |
126,915
+22,942
| +22% | +$2.34M | 0.29% | 70 |
|
|
2023
Q3 | $9.7M | Buy |
103,973
+70,923
| +215% | +$7.99M | 0.22% | 69 |
|
|
2023
Q2 | $4.25M | Buy |
33,050
+17,972
| +119% | +$2.17M | 0.12% | 82 |
|
|
2023
Q1 | $1.75M | Buy |
15,078
+6,333
| +72% | +$709K | 0.04% | 134 |
|
|
2022
Q4 | $991K | Buy |
8,745
+6,069
| +227% | +$666K | 0.03% | 155 |
|
|
2022
Q3 | $216K | Hold |
2,676
| – | – | 0.01% | 287 |
|
|
2022
Q2 | $199K | Sell |
2,676
-604
| -18% | -$55.1K | 0.01% | 293 |
|
|
2022
Q1 | $420K | Buy |
3,280
+2,200
| +204% | +$241K | 0.01% | 233 |
|
|
2021
Q4 | $146K | Sell |
1,080
-1,000
| -48% | -$144K | ﹤0.01% | 399 |
|
|
2021
Q3 | $285K | Buy |
2,080
+1,000
| +93% | +$126K | 0.01% | 312 |
|
|
2021
Q2 | $116K | Hold |
1,080
| – | – | ﹤0.01% | 396 |
|
|
2021
Q1 | $97K | Hold |
1,080
| – | – | ﹤0.01% | 448 |
|
|
2020
Q4 | $100K | Hold |
1,080
| – | – | ﹤0.01% | 386 |
|
|
2020
Q3 | $111K | Sell |
1,080
-320
| -23% | -$33.4K | ﹤0.01% | 328 |
|
|
2020
Q2 | $142K | Sell |
1,400
-600
| -30% | -$53.7K | ﹤0.01% | 299 |
|
|
2020
Q1 | $135K | Hold |
2,000
| – | – | 0.01% | 273 |
|
|
2019
Q4 | $109K | Hold |
2,000
| – | – | ﹤0.01% | 305 |
|
|
2019
Q3 | $75K | Sell |
2,000
-800
| -29% | -$31.1K | ﹤0.01% | 332 |
|
|
2019
Q2 | $105K | Buy |
2,800
+800
| +40% | +$25.1K | ﹤0.01% | 299 |
|
|
2019
Q1 | $60K | Sell |
2,000
-26,100
| -93% | -$917K | ﹤0.01% | 389 |
|
|
2018
Q4 | $842K | Sell |
28,100
-1,803,084
| -98% | -$57.2M | 0.03% | 163 |
|
|
2018
Q3 | $65.5M | Sell |
1,831,184
-594,952
| -25% | -$18.4M | 2.29% | 11 |
|
|
2018
Q2 | $57.6M | Sell |
2,426,136
-634,024
| -21% | -$13.4M | 2.11% | 13 |
|
|
2018
Q1 | $56.7M | Sell |
3,060,160
-4,024,072
| -57% | -$59.5M | 2.07% | 14 |
|
|
2017
Q4 | $102M | Buy |
7,084,232
+3,701,032
| +109% | +$48.1M | 1.83% | 13 |
|
|
2017
Q3 | $41.4M | Buy |
3,383,200
+222,668
| +7% | +$3.94M | 1.47% | 16 |
|
|
2017
Q2 | $57.8M | Buy |
3,160,532
+108,344
| +4% | +$2M | 2% | 11 |
|
|
2017
Q1 | $64.7M | Sell |
3,052,188
-415,816
| -12% | -$8.12M | 2.18% | 11 |
|
|
2016
Q4 | $51.8M | Buy |
3,468,004
+1,545,412
| +80% | +$27.4M | 1.52% | 16 |
|
|
2016
Q3 | $42.1M | Buy |
+1,922,592
| New | +$42.8M | 1.23% | 19 |
|
Other funds holding DXCM
VCM
VPM
Compagnie Lombard Odier SCmA's DXCM Position: Q1 2026 in Review
Compagnie Lombard Odier SCmA reduced its DexCom (DXCM) stake by 12% in Q1 2026, selling an estimated $1.87M and leaving 190,007 shares worth $11.9M. The position accounts for 0.15% of the portfolio, ranked #79.
Compagnie Lombard Odier SCmA first reported a position in DXCM in Q3 2016 and has held it in 39 quarters since. The position peaked at $102M in Q4 2017. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Compagnie Lombard Odier SCmA held 190,007 shares of DexCom worth $11.9M as of Q1 2026.
- Compagnie Lombard Odier SCmA sold 26,791 DexCom shares in Q1 2026, an estimated $1.87M.
- DexCom made up 0.15% of Compagnie Lombard Odier SCmA's portfolio in Q1 2026, its #79 holding.
- Compagnie Lombard Odier SCmA first reported a position in DexCom in Q3 2016 and has held it in 39 quarters since.
- Compagnie Lombard Odier SCmA's DexCom position peaked at $102M in Q4 2017.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2026, filed 15 Apr 2026.